Pelican Therapeutics Inc., which last year received a $15.2 million state grant to develop cancer-fighting immunotherapy treatments, has rejoined the publicly traded company that it spun out from more than four years ago.
Durham, North Carolina-based Heat Biologics Inc. (Nasdaq: HTBX) has agreed to buy a controlling stake in Austin-based Pelican for cash and stock in a deal valued at about $1.5 million, according to the Triangle Business Journal. More than 75 percent of Pelican shareholders have…
#URLinkedUp Austin Business News – Local Austin News | Austin Business Journal http://bit.ly/2mmOWO5
#Austin Check out URLinkedUp > http://bit.ly/1o4wis3